ABCB1 and breast cancer: A study showed that the increased calcium entry through transient receptor potential canonical (TRPC)5 channel up-regulated multidrug resistance pump (P-glycoprotein) leads to resistance in MCF-7 breast cancer cells when treated with Doxo [19].